Gene · 23049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The synergism of Lactobacillaceae, inulin, polyglucose, and aerobic exercise ameliorates hyperglycemia by modulating the gut microbiota community and the metabolic profiles in db/db mice. | Food Funct | 2024 | 38623620 | PubTator, text mining | PubMed |
| Improvement of catalysis performance of pepsin and lipase enzymes by double enzyme immobilization method. | RSC Adv | 2024 | 38590345 | PubTator, text mining | PubMed |
| Long non-coding RNA LIP interacts with PARP-1 influencing the efficiency of base excision repair. | Noncoding RNA Res | 2024 | 38577022 | PubTator, text mining | PubMed |
| Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain Barrier. | Mol Neurobiol | 2024 | 38558360 | PubTator, text mining | PubMed |
| In Vitro Cross-Linking MS Reveals SMG1-UPF2-SMG7 Assembly as Molecular Partners within the NMD Surveillance. | Int J Mol Sci | 2024 | 38542156 | PubTator, text mining | PubMed |
| Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol. | Curr Med Chem | 2024 | 38351696 | PubTator, text mining | PubMed |
| Role of UPF1 in lncRNA-HEIH regulation for hepatocellular carcinoma therapy. | Exp Mol Med | 2024 | 38297160 | PubTator, text mining | PubMed |
| A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells. | Heliyon | 2024 | 38268604 | PubTator, text mining | PubMed |
| Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. | Cell Death Discov | 2024 | 38267442 | PubTator, text mining | PubMed |
| Mechanism of Iron Ion Homeostasis in Intestinal Immunity and Gut Microbiota Remodeling. | Int J Mol Sci | 2024 | 38255801 | PubTator, text mining | PubMed |
| Aptamer-Based Smart Targeting and Spatial Trigger-Response Drug-Delivery Systems for Anticancer Therapy. | Biomedicines | 2024 | 38255292 | PubTator, text mining | PubMed |
| Inflammatory biotype of ADHD is linked to chronic stress: a data-driven analysis of the inflammatory proteome. | Transl Psychiatry | 2024 | 38238292 | PubTator, text mining | PubMed |
| Human brain representations of internally generated outcomes of approximate calculation revealed by ultra-high-field brain imaging. | Nat Commun | 2024 | 38233387 | PubTator, text mining | PubMed |
| External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry. | JACC Asia | 2024 | 38222252 | PubTator, text mining | PubMed |
| Risk factors for carotid plaque formation in type 2 diabetes mellitus. | J Transl Med | 2024 | 38178198 | PubTator, text mining | PubMed |
| Role of UPF1-LIN28A interaction during early differentiation of pluripotent stem cells. | Nat Commun | 2024 | 38167913 | PubTator, text mining | PubMed |
| A Comparative Transcriptomic Study and Key Gene Targeting of Lamprey Gonadal Immune Response. | Immunol Invest | 2024 | 38078455 | PubTator, text mining | PubMed |
| Exploring the cuproptosis-related molecular clusters in the peripheral blood of patients with amyotrophic lateral sclerosis. | Comput Biol Med | 2024 | 38056214 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion. | Bioact Mater | 2024 | 38024234 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23049/papers?page=9